Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism

IMPORTANCE: Extending the duration of oral anticoagulation for venous thromboembolism (VTE) beyond the initial 3 to 6 months of treatment is often recommended, but it is not clear whether clinical outcomes differ when using direct oral anticoagulants (DOACs) or warfarin. OBJECTIVE: To compare rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Margaret C., Reynolds, Kristi, Fan, Dongjie, Prasad, Priya A., Sung, Sue Hee, Portugal, Cecilia, Garcia, Elisha, Go, Alan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427945/
https://www.ncbi.nlm.nih.gov/pubmed/37581888
http://dx.doi.org/10.1001/jamanetworkopen.2023.28033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427945/
https://www.ncbi.nlm.nih.gov/pubmed/37581888
http://dx.doi.org/10.1001/jamanetworkopen.2023.28033

Ejemplares similares